ANAVEX LIFE SCIENCES CORP. AVXL
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2006-04-13
ANAVEX LIFE SCIENCES CORP. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 6,391,472 | $27.0M |
| TWO SIGMA INVESTMENTS, LP | 3,247,888 | $10.0M |
| CITADEL ADVISORS LLC | 1,172,035 | $3.6M |
| AQR CAPITAL MANAGEMENT LLC | 756,792 | $2.3M |
| RENAISSANCE TECHNOLOGIES LLC | 276,800 | $849,776 |
| D. E. Shaw & Co., Inc. | 44,856 | $137,708 |
Source: SEC EDGAR filings · CIK 0001314052 · as of 2025-09-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.